GB793491A - Process of recovering basic antibiotics - Google Patents
Process of recovering basic antibioticsInfo
- Publication number
- GB793491A GB793491A GB13576/56A GB1357656A GB793491A GB 793491 A GB793491 A GB 793491A GB 13576/56 A GB13576/56 A GB 13576/56A GB 1357656 A GB1357656 A GB 1357656A GB 793491 A GB793491 A GB 793491A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- salt
- amine
- amines
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Nitrogen basic antibiotics such as neomycin, streptomycin and streptothricin are recovered from a fermentation broth, or an acid filtrate thereof, by adsorption on a particulate cation exchanger in its amine salt form, and elution therefrom with a dilute mineral acid such as hydrochloric, nitric or sulphuric at pH 1.5 to 4.5. It is preferred however to elute with mineral acid of pH 4.5 to 6 to remove any alkali or alkaline earth metals before removing the antibiotic by elution at pH 1.5 to 4. Ion exchange resins deriving their exchange capacity essentially from carboxylic groups, e.g. Alkalex, "Amberlite" IRC-50 (Registered Trade Mark), "Duolite" CS 100 (Registered Trade Mark), "Permutit" H-70 (Registered Trade Mark), and "Wolfatit" C may be used. The cation exchanger is treated with the organic amine as such, if liquid, or in solution in water or aqueous organic solvent, e.g. aqueous ethanol, in order to be converted to the salt form. Specified amines are primary, secondary and tertiary aliphatic amines such as methylamine, diethylamine and triethylamine, the primary, secondary and tertiary cycloaliphatic amines, e.g. cyclobutylamine; the primary, secondary and tertiary araliphatic amines, e.g. benzylamine; and heterocyclic amines, e.g. piperidine, pyrrolidine morpholine and their alkyl substituted derivatives. Preferably the amine is such that its salt with the eluting acid has a different solubility from the salt of the antibiotic with the eluting acid. The process may be batch or continuous. It is preferred to use the acid filtrate obtained by acidifying the broth to a pH of 1.5 to 3 with mineral acid and filtering with a filter aid. The pH is then adjusted to pH 5 to 9.5, and preferably 7 to 8.5 with an amine. If desired, a sequestering agent for alkaline earth cations, ethylenediamine tetraacetic acid may be added to the acid or neutralized filtrate before the adsorption step. After elution, the eluate is adjusted to pH 5 to 7 by means of an anion exchange resin, e.g. "Amberlite" IR-4B, concentrated if desired, and the antibiotic precipitated by means of a non-solvent in which the salt of the amine with the eluting acid is soluble. Such solvents are the water-miscible alcohols, e.g. methanol and ethanol; the watermiscible ketones, e.g. acetone; the watermiscible ethers, e.g. dioxane; water-miscible nitriles, e.g. acetonitrile and the water-miscible amides, e.g. dimethyl formamide. The antibiotic salt may be vacuum or freeze dried or converted to the free base.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US793491XA | 1955-06-27 | 1955-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB793491A true GB793491A (en) | 1958-04-16 |
Family
ID=22149965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB13576/56A Expired GB793491A (en) | 1955-06-27 | 1956-05-02 | Process of recovering basic antibiotics |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB793491A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3147245A (en) * | 1961-02-03 | 1964-09-01 | Rohm & Haas | Pharmaceutical purification process |
US3277078A (en) * | 1963-03-23 | 1966-10-04 | Takeda Chemical Industries Ltd | Zygomycin a1 and zygomycin a2 and their isolation |
-
1956
- 1956-05-02 GB GB13576/56A patent/GB793491A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3147245A (en) * | 1961-02-03 | 1964-09-01 | Rohm & Haas | Pharmaceutical purification process |
US3277078A (en) * | 1963-03-23 | 1966-10-04 | Takeda Chemical Industries Ltd | Zygomycin a1 and zygomycin a2 and their isolation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1283811A (en) | 3-mercaptothiazole or mercaptotetrazole cephalosporins and process for preparing the same | |
US3707536A (en) | Process for the isolation and purification of s-adenosyl methionine and ethionine and novel sulfates thereof | |
GB793491A (en) | Process of recovering basic antibiotics | |
US2969353A (en) | Process for the preparation of "active methionine" and products obtained thereby | |
US2793978A (en) | Ion exchange purification of neomycin | |
GB1352270A (en) | Recovering and purifying antibiotics | |
US2789983A (en) | Recovery of cycloserine | |
GB931954A (en) | Improvements in or relating to the preparation of crystalline insulin | |
US2537941A (en) | Recovery of streptomycin | |
GB1265315A (en) | ||
IL43341A0 (en) | Process for the recovery of fluorine from an aqueous solution by ion exchange | |
GB881855A (en) | Elution of organic substances from ion-exchange resins | |
GB782926A (en) | Purification of polymyxin | |
GB937327A (en) | Process for the preparation of codehydrogenase i (diphosphopyridine nucleotide) of high purity from yeast | |
US3271386A (en) | 5-amino-4-imidazolecarboxamide riboside recovery process | |
US2834711A (en) | Production of bacitracin | |
NL151436B (en) | PROCESS FOR PREPARING AN ANTIBIOTIC BY A STREPTOMYCETE, OF THE SPECIES STREPTOMYCES RIMOSUS. | |
GB1453063A (en) | Method for purifying 3,5-cyclic-adenylic acid or 3,5-cyclic- deoxy-adenylic acid | |
GB913578A (en) | Preparation of tetracycline and tetracycline-urea compounds | |
GB886989A (en) | Process for the preparation of purified solutions of the callicrein inactivator | |
GB1038538A (en) | Process for isolating tetracycline in crystalline form | |
GB683254A (en) | Improvements in or relating to a process of purifying erythrotin (vitamin b) | |
GB1497157A (en) | Process of preparing 7-mono-o-(beta-hydroxyethyl)-rutosid | |
GB757089A (en) | Improvements in or relating to antibiotics | |
GB2012270A (en) | Crystallisation process for sodium cefuroxime |